Loading provider…
Loading provider…
Anatomic Pathology & Clinical Pathology Physician in San Francisco, CA
NPI: 1447556352HQ Phone
Get M.D. Arnold's Phone Numberphone_androidMobile
Get M.D. Arnold's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1988 - 2025
FL State Medical License
2012 - 2016
NJ State Medical License
2012 - 2015

American Board of Pathology
Anatomic Pathology

American Board of Pathology
Clinical Pathology

American Board of Pathology
Immunopathology
Stanford University School Of Medicine
med.stanford.edu
Medical School
Until 1987
University of California (San Francisco) School of Medicine
Residency • Laboratory Medicine (Clinical Pathology)
1993 - 1994
UCSF School of Medicine
medschool.ucsf.edu
Fellowship • Hematopathology
1994 - 1995
Stanford Health Care
Fellowship • Immunopathology
1991 - 1993
Stanford Health Care-Sponsored Stanford University Surgical Pathology
Fellowship • Selective Pathology
1990 - 1991
Stanford Health Care-Sponsored Stanford University
Residency • Pathology-Anatomic and Clinical
1988 - 1990
University of Chicago
Internship • Internal Medicine
1987 - 1988
Langerhans' cell histiocytosis presenting with the superior vena cava syndrome: a case report.
Authors: Michael Link, Sarah Donaldson, Bertil Glader, Gary Hartman
Journal: Med Pediatr Oncol
Authors: Lopes de Menezes, Daniel E, Denis-Mize, Kimberly, Tang, Yan, Ye, Helen, Kunich, John C, Garrett, Evelyn N, Peng, Jing, Cousens, Lawrence S, Gelb, Arnold B, Heise, Carla, Wilson, Susan E, Jallal, Bahija, Aukerman, Sharon L
Journal: J Immunother
Lead Sponsor: Alaunos Therapeutics
Intervention / Treatment: BIOLOGICAL: Ad-RTS-hIL-12, DRUG: Veledimex, DRUG: Cemiplimab-Rwlc
Lead Sponsor: Alaunos Therapeutics
Intervention / Treatment: BIOLOGICAL: Ad-RTS-hIL-12, DRUG: veledimex
Lead Sponsor: Alaunos Therapeutics
Intervention / Treatment: DRUG: Nivolumab, BIOLOGICAL: Ad-RTS-hIL-12, DRUG: veledimex